Disease Overview：Pulmonary Valve Stenosis（PVS）
Pulmonary valve stenosis (PVS) is a congenital or acquired cardiovascular condition characterized by narrowing of the pulmonary outflow tract, most commonly at the level of the pulmonary valve. This obstruction impedes blood flow from the right ventricle to the pulmonary arteries, leading to right ventricular hypertrophy, elevated systolic pressure gradients, and, if severe, symptoms such as dyspnea, fatigue, syncope, or right heart failure. Diagnosis relies on echocardiography—particularly Doppler assessment of peak instantaneous gradient—and may be supplemented by cardiac MRI or catheterization for hemodynamic quantification. Treatment indications depend on gradient severity (>50 mmHg at rest), symptom status, and ventricular function; options include balloon pulmonary valvuloplasty (BPV), surgical valvotomy, or, in complex cases, transcatheter pulmonary valve replacement (TPVR). Long-term prognosis is generally excellent following successful intervention, with low procedural mortality and high freedom from reintervention.
China offers distinct advantages for PVS management: its top-tier cardiovascular centers—many accredited by international bodies like JCI—employ world-class interventional cardiologists with extensive experience in both BPV and next-generation TPVR platforms (e.g., Melody, SAPIEN valves). Advanced imaging integration (3D echo, fusion imaging) enhances procedural precision, while robust registries document >95% procedural success rates and <1% major complication incidence across high-volume hospitals. Crucially, treatment costs in China are typically 40–60% lower than in the US or Western Europe without compromising clinical standards—balloon valvuloplasty starts at approximately USD 8,000–12,000, including diagnostics and hospital stay. As your dedicated medical tourism agency, we streamline the entire journey: verifying physician credentials, securing appointments at vetted hospitals, providing itemized, transparent pricing, coordinating visas and accommodation, and assigning bilingual case managers for end-to-end support—from pre-travel consultation to post-discharge follow-up.
Pulmonary Valve Stenosis: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Pulmonary Valve Stenosis (Cardiovascular Department)
Non-Surgical / Conservative Management
*Indicated for mild stenosis (peak gradient <30 mmHg), asymptomatic patients, or those unfit for intervention.*
- •Monitoring: Annual echocardiography + ECG + clinical assessment
- Resting ECG: $15–$25 - Cardiology outpatient visit (consultation + review): $45–$75
- •Medications (only for symptom control or comorbidities; *no drug treats PVS itself*):
- Diuretics (if right heart failure develops): $5–$10/month
- •Lifestyle counseling & activity restriction guidance: Included in outpatient visit fee
Surgical & Interventional Procedures
*Eligibility: Moderate–severe stenosis (peak gradient ≥40 mmHg), symptoms (dyspnea, syncope), RV hypertrophy, or progressive hemodynamic deterioration.*
- •Balloon Pulmonary Valvuloplasty (BPV) — *First-line for typical valvar PVS*
- Procedure (cath lab, fluoroscopy, balloon dilation, same-day discharge): $3,800–$5,200 - Post-procedure TTE + 24-hr monitoring: $150–$200
- •Surgical Pulmonary Valvotomy or Valve Replacement — *For dysplastic valves, hypoplastic annulus, or BPV failure*
- Open-heart surgery (CPB, median sternotomy, valve repair/replacement): $9,500–$14,200 - Includes ICU stay (2–3 days), post-op echo, and 7-day hospitalization - Bioprosthetic valve (e.g., porcine): + $1,800–$2,600 - Mechanical valve: + $1,200–$1,700
Special/Complex Condition Management
- •PVS with Tetralogy of Fallot or other cyanotic CHD: Requires staged palliation → full repair. Total cost: $12,000–$18,500, including shunt procedure ($4,200–$6,000) + definitive repair.
- •Adults with severe calcified PVS + pulmonary artery hypoplasia: Hybrid approach (surgical enlargement + BPV) — $10,800–$15,600.
- •Re-intervention after BPV restenosis: Repeat BPV costs $3,600–$4,900, including revised pre-op imaging (CT/MRI).
Quick Selection Guide
- •Children (<12 yrs), isolated valvar PVS, gradient 40–80 mmHg: Balloon valvuloplasty — optimal safety, efficacy, lowest cost ($4,200 avg).
- •Adults with dysplastic valve or annular hypoplasia: Surgical valvotomy or bioprosthetic replacement — avoids long-term reintervention risk.
- •Budget-constrained patients (mild–moderate, asymptomatic): Conservative monitoring only — $200–$300/year; defer intervention until progression.
- •Severe PVS + RV dysfunction or cyanosis: Urgent surgical referral — avoid BPV; higher upfront cost justified by durability and hemodynamic rescue.
- •Elderly patients (>70 yrs) with multiple comorbidities: Individualized decision — BPV preferred if anatomy favorable; otherwise optimized medical support + palliative monitoring.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Pulmonary Valve Stenosis Medical Vacation Packages
Curated transparent all-inclusive packages combining Pulmonary Valve Stenosis treatment with China top medical destinations:
